March 14th, 2021

Really Rapid Review — CROI 2021 Virtual

For a few years in the early 2010s, the Conference on Retroviruses and Opportunistic Infections (CROI) — in my opinion our premiere HIV scientific meeting — covered almost as many hepatitis C clinical trials as those on HIV. Or at least it seemed that way.

This made sense at the time — the startling success of non-interferon-based HCV treatments made for exciting news, and rapid progress. Here’s what I wrote in 2013 in another patented, copyrighted, and trademarked CROI Really Rapid Review™, for which NEJM Journal Watch receives many millions of dollars in royalties:

The results of the sofosbuvir and ledipasvir study — 100% response in both naives and prior null responders — provided one of the more exciting clinical trial results I’ve seen in years, small sample size notwithstanding.

Remember those days? Well, this CROI had barely any HCV at all, a sign of progress.

(And I was kidding about the royalties, in case you were wondering.)

Of course, in 2021 we are in the midst of a pandemic, so it’s not surprising that this CROI had plenty of COVID-19 studies, both on COVID-19 alone and on the combination of HIV and COVID-19. Here are some highlights, starting with HIV, then the HIV/COVID-19 studies, and then some interesting COVID-19 alone papers.

The links are to the presented abstracts, which requires a conference account (at least it does today) — however, as with other HIV meetings, plenty of the presented material appears on the invaluable NATAP page.

You’ll note I started and finished this post mentioning hepatitis C studies — which due to our success in treatment now have a very small footprint at CROI. Let’s hope the same happens to COVID-19 in the not-so-distant future!

And since this CROI was supposed to be Chicago and bring in people from all over the country (and the world), here’s a wonderful tour around North American accents, with of course a stop in the land of da Bears — right around 3’40”.

 

2 Responses to “Really Rapid Review — CROI 2021 Virtual”

  1. Sylvain Meylan says:

    Hi Paul! You may not get royalties but your white coat will be retired by the BWH and you will be a first round pick for the NEJM hall of fame. Best regards, Sylvain.

  2. Shubha Kerkar says:

    Thank you for a balcony View -of CROI and for a great Rapid -yet sumptuous summary of CROI 2021!!

Leave a Reply

Your email address will not be published. Required fields are marked *

Note: This is a moderated forum. By clicking on the "Submit Comment" button below, you agree to abide by the NEJM Journal Watch Terms of Use.

Our physician bloggers cannot respond to requests for personal medical advice, and recommend patients discuss health issues with their individual physicians.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

HIV Information: Author Paul Sax, M.D.

Paul E. Sax, MD

Contributing Editor

NEJM Journal Watch
Infectious Diseases

Biography | Disclosures | Summaries

Learn more about HIV and ID Observations.